Product NDC: | 0338-0147 |
Proprietary Name: | PLASMA-LYTE 56 AND DEXTROSE |
Non Proprietary Name: | Dextrose Monohydrate, Sodium Chloride, Potassium Acetate, Magnesium Acetate Tetrahydrate |
Active Ingredient(s): | 5; 32; 128; 224 g/100mL; mg/100mL; mg/100mL; mg/100mL & nbsp; Dextrose Monohydrate, Sodium Chloride, Potassium Acetate, Magnesium Acetate Tetrahydrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-0147 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017385 |
Marketing Category: | NDA |
Start Marketing Date: | 19790201 |
Package NDC: | 0338-0147-04 |
Package Description: | 1000 mL in 1 BAG (0338-0147-04) |
NDC Code | 0338-0147-04 |
Proprietary Name | PLASMA-LYTE 56 AND DEXTROSE |
Package Description | 1000 mL in 1 BAG (0338-0147-04) |
Product NDC | 0338-0147 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dextrose Monohydrate, Sodium Chloride, Potassium Acetate, Magnesium Acetate Tetrahydrate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19790201 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | DEXTROSE MONOHYDRATE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE |
Strength Number | 5; 32; 128; 224 |
Strength Unit | g/100mL; mg/100mL; mg/100mL; mg/100mL |
Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |